ACXP - Acurx Pharmaceuticals LLC

Acurx Pharmaceuticals, LLC, a clinical-stage biopharmaceutical company, develops antibiotics to treat bacterial infections. The company is headquartered in Staten Island, New York.

52W High

$44.00

52W Low

$3.80

MA Status:

50D: Below 200D: Below

Beta (~1 neutral, <0.9 lower risk)

-1.29

Valuation

As of 2025-06-30 (Overview)

Trailing P/E (<15 better)

N/A

Forward P/E (<15 better)

N/A

EV/EBITDA (<8 favorable)

-3.54

EV/Revenue (<3 favorable)

N/A

P/S (TTM) (<3 favorable)

N/A

P/B (<3 favorable)

1.81

Ownership

Retail‑heavy

Source: Overview

Insiders (1–5% typical)

8.12%

Institutions (25–75% balanced)

13.95%

Shares Outstanding

1,584,800

Float

1,311,700

Dividend Yield (2–6% sweet spot)

N/A

Ex‑Dividend Date

N/A

Income & Growth

Profitability: Weak

As of 2025-06-30 (Overview)

Revenue (TTM)

Gross Profit (TTM)

EPS (TTM)

-10.57

Profit Margin (>10% good)

N/A

Operating Margin (TTM) (higher better)

N/A

ROE (TTM) (>15% strong)

-2.86%

EPS YoY (Quarterly) (>10% good)

N/A

Revenue YoY (Quarterly) (>8% good)

N/A

Momentum

Bearish momentum

Value

-0.5955

-0.6450

Trend

Rising

Signal Cross

No cross

As of

Sep. 12, 2025